Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38+0.04 (+12.53%)
Close on Nov 17, 2026Market cap $48.77MP/E –Yield –
Oncolytics Biotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2024 it was -C$34.86M. The highest annual figure on record is -C$13.74M in fiscal 2015.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -C$34.86M | – |
| FY2023 | Dec 31, 2023 | -C$33.71M | – |
| FY2022 | Dec 31, 2022 | -C$26.83M | – |
| FY2021 | Dec 31, 2021 | -C$26.11M | – |
| FY2020 | Dec 31, 2020 | -C$25.37M | – |
| FY2019 | Dec 31, 2019 | -C$20.25M | – |
| FY2018 | Dec 31, 2018 | -C$17.18M | – |
| FY2017 | Dec 31, 2017 | -C$15.51M | – |
| FY2016 | Dec 31, 2016 | -C$15.13M | – |
| FY2015 | Dec 31, 2015 | -C$13.74M | – |
See a number that looks wrong?